SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001804220-23-000015
Filing Date
2023-05-04
Accepted
2023-05-04 07:11:46
Documents
15
Period of Report
2023-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K regn-20230504.htm   iXBRL 8-K 32306
2 EXHIBIT 99.1 exhibit991q12023.htm EX-99.1 345640
6 image0a12.jpg GRAPHIC 7835
  Complete submission text file 0001804220-23-000015.txt   560291

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT regn-20230504.xsd EX-101.SCH 2249
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT regn-20230504_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT regn-20230504_pre.xml EX-101.PRE 12943
9 EXTRACTED XBRL INSTANCE DOCUMENT regn-20230504_htm.xml XML 11568
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 23886432
SIC: 2834 Pharmaceutical Preparations